Empowering researchers and growing companies with advanced imaging technology and expert support Jena, Germany/ Manchester, United Kingdom | ZEISS Research Microscopy Solutions Bruntwood SciTech, the UK’s leading developer of innovation districts, and ZEISS have announced a strategic partnership designed to support life science research and accelerate innovation across the UK. The partnership brings the advanced […]

The nonprofit consortium is advancing open-source foundation models and software infrastructure for biology and drug discovery. BERKELEY, Calif. — OpenFold Consortium, an open science initiative advancing open-source AI tools for biology and drug discovery, announced today that eleven new members have joined the consortium including Absci, Adaptive Biotechnologies, Benchling, Chemical Computing Group, Daiichi Sankyo, Flagship […]

CellVoyant and Axol Bioscience announce strategic collaboration to advance AI-guided predictive imaging assays for cardiomyocyte manufacturing Collaboration combines CellVoyant AI-powered FateView™ platform with Axol Bioscience induced pluripotent stem cell (iPSC) expertise to enable predictive, non-destructive assessment of cardiomyocyte differentiation processes, enabling the generation of highly pure cell populations at scale. BRISTOL, UK and EDINBURGH, UK […]

Partnership provides Human Cell Atlas members with access to the Tapestri Platform for integrated single-cell DNA, RNA, and protein analysis SAN FRANCISCO — Mission Bio, the leader in single-cell multiomics solutions, today announced a collaboration with the Human Cell Atlas (HCA), a global consortium working to create comprehensive reference maps of all human cells to advance the […]

Covalent today announced a strategic collaboration with Oxford Instruments that expands its semiconductor characterisation offering with customer-ready, wafer-level Raman and photoluminescence (PL) workflows. The capability is now available to customers investigating defect density, mapping stress and strain, developing processes, and carrying out failure analysis at full-wafer scale. As materials such as silicon carbide (SiC) and […]

Alithea Genomics, a pioneering biotech company specializing in scalable RNA sequencing solutions, today announced a new agreement with Revvity Inc. to broaden access to MERCURIUS™ DRUG-seq and MERCURIUS™ Total DRUG-seq solutions through Revvity’s global commercial network.  The collaboration brings together Alithea Genomics’ scalable high-throughput transcriptomics technologies with Revvity’s comprehensive drug discovery and screening portfolio, enabling […]

Melbourne, Australia – Legion BioSolutions Limited and OnQ Software Pty Ltd are pleased to announce that they have signed a dealer agreement appointing Legion BioSolutions as the regional partner for QLIMS, OnQ Software’s flagship laboratory information management system, across the genomics sector in the United Arab Emirates, Saudi Arabia, Bahrain, Kuwait, Oman, Qatar, and Jordan. Under […]

SOPHiA GENETICS and Memorial Sloan Kettering Cancer Center Aim to Establish Precision Medicine Hub for the Next Generation of Precision Oncology NEW YORK — SOPHiA GENETICS (NASDAQ: SOPH) today announced that the company has signed a Memorandum of Understanding (MOU) with Memorial Sloan Kettering Cancer Center (MSK) relating to the formation of a joint venture between the two […]

New integrated workflow combines icIEF fractionation and mass photometry Enables direct characterization of aggregation and size within icIEF-resolved charge variants Four-hour workflow reduces development risk and accelerates biosimilar manufacturing MINNEAPOLIS and OXFORD, England — Bio‑Techne Corporation (NASDAQ: TECH), a global provider of life science tools, reagents and diagnostic products, and Refeyn, the pioneer in mass photometry technology, […]

Strategic partnership integrates Pluristyx’s clinical-grade iPSC platform into Made Scientific’s CDMO services, giving developers a single-source path from cell line to commercial supply. PRINCETON, N.J. and SEATTLE — Made Scientific, Inc., a leading U.S.-based clinical- and commercial-stage cell therapy contract development and manufacturing organization (CDMO), and Pluristyx, a leading provider of RUO and GMP induced […]